Article Details
Retrieved on: 2021-08-04 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zymergen, a synthetic biology company that completed its IPO in April, plunged as much as 77% on Wednesday after the company said that product ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here